Hahn-Schickard-Gesellschaft of Villingen-Schwenningen, Germany, has received US Patent No. 8,096,314, "Fluidic device, fluidic module, and method of handling a liquid." The described device is capable of switching liquids, where the corresponding fluidic structures may also be referred to as switches or valves. These fluidic structures may include a radially interior first fluid chamber, a radially exterior second fluid chamber, and a connection, for example a constriction, at which a meniscus may be built up and stabilized up to a certain rotational frequency.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.